San Francisco-based Checkr has seen its revenues jump 14% to $800 million as companies try to spot a flood of AI-generated CVs and faked financial documents.
Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.
An outcry over insider trading erupted after one Polymarket user made $400,000 betting that Maduro would be ousted, hours before it happened. Here’s why the godfather of prediction markets thinks it’s a good thing.
The electric vehicle maker used just 70% of its plant capacity last year – a level comparable to traditional auto rivals. Things could get worse in 2026.
After a decade of modest gains, data storage companies like Sandisk, Seagate and Western Digital had a stunning run in 2025.
Former SpaceX propulsion CTO Thomas Mueller’s space startup reached unicorn status this year thanks to $525 million in funding since 2021. It’s just one of 141 other startups founded by SpaceX alumni.
Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
Record activity in the AI sector this year has boosted dozens of founders and business executives into the billionaire ranks.
OpenAI wanted GPT-5 to be less warm and agreeable than its predecessor. Some neurodivergent people struggled with the change, showing the tricky balance AI companies must strike when releasing new models.